SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

CORRESP Filing

iBio, Inc. (IBIO) (CIK 0001420720)
Date: June 18, 2025 · CIK: 0001420720 · Accession: 0001104659-25-060671

Offering / Registration Process

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-28800

Date
June 18, 2025
Author
Chief Legal Officer
Form
CORRESP
Company
iBio, Inc. (IBIO) (CIK 0001420720)

Letter

VIA EDGAR United States Securities Division of Corporation Finance Attention: Lauren Hamill Re: iBio, Inc. Registration Statement on Form S-3 Filed June 13, 2025 File No: 333-28800

Dear Ms. Hamill:

iBio, Inc. (the " Registrant ") hereby requests that the effective date of the above-referenced Registration Statement on Form S-3 (File No. 333-28800), be accelerated by the U.S. Securities and Exchange Commission (the " Commission ") to become effective on Monday, June 23, 2025 , at 5:00 p.m ., Eastern Time, or as soon as reasonably practicable thereafter.

The Registrant understands that the Staff of the Commission will consider this request as confirmation by the Registrant that it is aware of its responsibilities under the federal securities laws as they relate to the issuance of the securities covered by the Registration Statement.

The Registrant hereby authorizes Leslie Marlow and/or Melissa Murawsky of Blank Rome LLP to orally modify or withdraw this request for acceleration. Please contact Ms. Marlow at (212) 885-5358 or Ms. Murawsky n at (215) 569-5732 with any questions you may have concerning this request, and please notify either of them when this request for acceleration has been granted.

Thank you.

Very truly yours,
IBIO, INC.

Show Raw Text
CORRESP
 1
 filename1.htm

 June 18, 2025

 VIA EDGAR

 United States Securities

 and Exchange Commission

 Division of Corporation Finance

 100 F Street, N.E.

 Washington, D.C. 20549

 Attention: Lauren Hamill

 Re:
 iBio, Inc.

 Registration Statement on Form S-3

 Filed June 13, 2025
 File No: 333-28800

 Dear Ms. Hamill:

 iBio, Inc. (the " Registrant ")
hereby requests that the effective date of the above-referenced Registration Statement on Form S-3 (File No. 333-28800), be accelerated
by the U.S. Securities and Exchange Commission (the " Commission ") to become effective on Monday, June 23, 2025 ,
at 5:00 p.m ., Eastern Time, or as soon as reasonably practicable thereafter.

 The Registrant understands
that the Staff of the Commission will consider this request as confirmation by the Registrant that it is aware of its responsibilities
under the federal securities laws as they relate to the issuance of the securities covered by the Registration Statement.

 The Registrant hereby authorizes
Leslie Marlow and/or Melissa Murawsky of Blank Rome LLP to orally modify or withdraw this request for acceleration. Please contact Ms.
Marlow at (212) 885-5358 or Ms. Murawsky n at (215) 569-5732 with any questions you may have concerning this request, and please notify
either of them when this request for acceleration has been granted.

 Thank you.

 Very truly yours,

 IBIO, INC.

 By:
 /s/ Marc Banjak

 Name:
 Marc Banjak

 Title:
 Chief Legal Officer

 cc: Leslie Marlow, Blank Rome LLP
 Melissa Murawsky, Blank Rome LLP